Rotaviruses are composed of a segmented double-stranded RNA genome surrounded by three concentric layers of proteins (20) . VP4, the protein forming the spikes that extend from the surface of the virus particle, is involved in a variety of viral functions, including cell attachment (1, 5, 16, 19) and penetration (2) .
Most rotavirus strains isolated from animals are able to agglutinate erythrocytes, and VP4 has been identified as the virus hemagglutinin (7, 13) . VP4 requires no other rotavirus protein to hemagglutinate (13) , and expression of truncated versions of the VP4 gene in bacteria (10) and insect cells (3) has shown that the hemagglutination (HA) domain of the protein lies in VP8, the smallest trypsin cleavage polypeptide of VP4.
Rotavirus HA is mediated by the sialic acid moiety of glycophorin A (gphA) (5, 13) and can be abolished by treatment of erythrocytes with neuraminidase (NA) and by incubation of the virus with soluble gphA (5, 13, 16) . The binding of animal rotaviruses to target epithelial cells is also mediated by sialic acids (5, 8, 16, 22) , and several sialoglycoproteins have been shown to inhibit the replication of the virus both in vivo and in vitro (23) . In contrast to animal rotaviruses, human rotaviruses do not hemagglutinate, and their infectivity is neither dependent on the presence of sialic acids on the cell surface nor inhibited by gphA (5) .
It has been reported that the minimal region of VP4 that still retains the binding domain for VP8-specific neutralizing monoclonal antibodies (MAbs) consists of amino acids 55 to 222 of VP4 (14) , suggesting that the VP8 polypeptide has a conformation that can be lost by further deletions. Therefore, to map the HA domain on VP4 while preserving the overall protein structure, we evaluated the approach of constructing full-length chimeras between the VP4 genes of hemagglutinating (porcine YM) and nonhemagglutinating (human KU) rotavirus strains. The parental and chimeric genes were expressed in insect cells by using the baculovirus system, and the HA ability of the synthesized proteins was tested.
Plasmid constructions were carried out by using standard recombinant DNA techniques. Cloning of the chimeric and parental YM and KU VP4 genes has been described elsewhere (4, 6) . To test for the integrity of the chimeric genes, selected plasmid constructs were in vitro transcribed, translated in a rabbit reticulocyte lysate, and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as described previously (11) . A diagram of the chimeric proteins is shown in Fig. 1 . For the construction of recombinant baculoviruses, YM, QYM, QKU, and QC VP4 genes were subcloned in transfer vector pVL1392 (Invitrogen), and the KU VP4 gene was subcloned in pBlueBac 2 (Invitrogen) (4) . Recombinant baculoviruses were isolated by limiting dilution, using an immunocytochemistry assay to detect the viruses expressing the VP4 protein (4, 10) . The recombinant VP4 proteins were produced by infecting Spodoptera frugiperda Sf9 cells at a multiplicity of infection of Ͼ2 with the wild-type (wt) or recombinant baculoviruses; at the indicated times, the cells were harvested in TE buffer (50 mM Tris hydrochloride [pH 7.5], 0.1 mM EDTA) containing a cocktail of protease inhibitors, sonicated, and centrifuged as described previously (4) . The cell pellet was resuspended in TE buffer plus protease inhibitors and used in HA and HA inhibition (HAI) assays and for SDS-PAGE analysis.
Baculovirus expression of the VP4 genes. All recombinant viruses directed the synthesis of a polypeptide with the expected molecular mass of about 86.5 kDa that was absent in Sf9 cells infected with wt Autographa californica nuclear polyhedrosis virus (AcNPV) (Fig. 2) . Densitometric analysis of the gel showed that the putative VP4 protein represented about 10% of the total cellular protein for YM VP4 and chimera QYM and between 1 and 2% for KU VP4 and chimeras QKU and QC. All parental and chimeric VP4 proteins were found associated to the insoluble cell fraction after disruption of the cells by sonication and low-speed centrifugation.
The identity of the VP4 proteins was established by immunoprecipitation. Sf9 cells infected with the various recombinant baculoviruses were pulse-labeled with [
35 S]methionine for 4 h at 2 days postinfection (p.i.), and the labeled proteins were analyzed by SDS-PAGE before and after immunoprecipitation with a mix of hyperimmune sera directed to the YM and Wa rotavirus particles (Fig. 3) . The serum immunoprecipitated a major band of the expected molecular weight from the cells infected with each of the recombinant baculoviruses but not from cells infected with the wt virus.
Of interest, the amounts of the various parental and chimeric VP4 proteins synthesized during a 4-h labeling period at 2 days p.i. were different, relative to each other, compared with the accumulated protein detected by Coomassie blue staining at 4 days p.i. For instance, the QC hybrid protein seems to be synthesized to a level similar to that of the QYM and parental YM VP4 proteins (Fig. 3A , lanes YM, QYM, and QC); however, when the accumulated protein was analyzed, QC was evidently less abundant than the other two proteins (Fig. 2 , lanes YM, QYM, and QC), suggesting that it is less stable and does not accumulate efficiently. Chimeras QKU and KU also seem to be less stable than YM VP4 and QYM.
HA and HAI of baculovirus-expressed parental VP4 proteins. Sf9 cells infected with the recombinant baculoviruses were harvested at 2 days p.i. and sonicated, and the insoluble pelleted fraction was tested for HA of human type O erythrocytes. The HA activity of the YM VP4 protein was easily detected, and it could reach a titer of up to 1:1,024, while KU VP4 consistently failed to hemagglutinate (Fig. 4A) . One HA (4). Nondenatured cell lysates were analyzed by SDS-PAGE and fluorography before (A) and after (B) immunoprecipitation with a 1:1 mix of rabbit hyperimmune anti-YM and anti-Wa sera as described previously (11, 18) . The position of the VP4 proteins is indicated.
FIG. 4. (A)
HA activity of baculovirus-expressed YM and KU VP4 proteins. Sf9 cells infected with recombinant baculoviruses were harvested at 2 days p.i. and treated as described in the text. HA was carried out for 2 h at 4ЊC as previously reported (10) . Numbers on top designate dilution factors of the baculovirus-infected Sf9 cell lysates used. (B) HAI assay. The HA activity of the recombinant proteins was not stable; the HA titer could decrease up to 10-fold if the HA was evaluated 2 h after the sample had been harvested. Therefore, the HAI assay was performed as follows. Serial twofold dilutions of the Sf9 cell lysates containing the recombinant protein were incubated for 10 min at 4ЊC with an equal volume of either hyperimmune anti-YM serum diluted 1:1,000 or 200 ng of gphA. An equal volume of 0.4% human type O erythrocytes was then added, and the plates were incubated for 2 h at 4ЊC. The effect of NA treatment of erythrocytes on YM VP4 HA (rbcϩNA) was evaluated by carrying out an HA assay with erythrocytes treated with Arthrobacter ureafaciens NA as described previously (16 Incubation with hyperimmune anti-YM serum or gphA reduced the HA titer of YM VP4 16-and 32-fold, respectively, while the NA treatment of erythrocytes completely abolished the HA activity (Fig. 4B) , showing that the HA was specific. Incubation with the rabbit preimmune serum did not modify the HA titer of YM VP4 (not shown). For comparison, under the same conditions, the HA of rotavirus YM (HA titer 1:256) was abolished by incubation with either NA-treated erythrocytes or the anti-YM serum and was decreased 4-fold by gphA. In some experiments, Sf9 cells infected with wt AcNPV, and treated in the same way as the cells infected with the recombinant viruses, showed an atypical HA activity at a dilution 1:4 (the lowest dilution tested), but this HA was not inhibited by the treatments that reduced or abolished the HA of the YM VP4 protein.
HA and HAI of chimeric VP4 proteins. The ability of the chimeric proteins to agglutinate human type O erythrocytes was tested with samples harvested at 2 days p.i. The chimera QYM did not hemagglutinate, while chimeras QKU and QC hemagglutinated to a titer of 1:64 ( Fig. 5; 1 HA unit was achieved with about 30 to 50 ng of either hybrid VP4 protein). The HA activity of chimeras QKU and QC was also shown to be specific, since it was completely abolished by incubation with hyperimmune serum to rotavirus YM or by the treatment of erythrocytes with NA (Fig. 5) . The HA titer of these proteins was also reduced 16-fold by incubation with hyperimmune anti-Wa serum (shown for QKU in Fig. 5A ). In addition, incubation with soluble gphA caused a 16-fold reduction in the HA titer of chimera QKU and abolished the HA activity of the QC protein.
Antigenicity of parental and chimeric VP4 proteins. To detect possible conformational changes in the chimeric VP4 proteins, the reactivities of a panel of MAbs directed to the VP5 and VP8 regions of VP4 and of hyperimmune sera raised against the complete YM or Wa virus particles were analyzed. The antibody reactivity was evaluated by two methods: (i) by immunoprecipitation of [
35 S]methionine-labeled proteins synthesized with the vaccinia virus-T7 RNA polymerase transient expression system, as described previously (18) , and (ii) by immunocytochemistry of Sf9 cells infected with recombinant baculoviruses. In both methods, the hyperimmune sera and the two MAbs directed at VP5 (MAbs YO-2C2 [21] and HS2 [17] , derived from human rotavirus strains YO and ST3, respectively) recognized the parental as well as the three chimeric VP4 proteins to similar degrees ( Table 1 ). The interaction of YO-2C2 with YM VP4 and chimera QYM was unexpected, since the binding site for this MAb has been shown to be a continuous epitope comprised within amino acids 296 and 313 of KU VP4 (21) , and YM VP4 has 6 amino acid differences in this region compared with KU VP4 (12); accordingly, when higher dilutions of MAb YO-2C2 were used, YM VP4 was no longer detected, while KU VP4 was still efficiently recognized.
The VP8-specific MAbs 2B6, 4B2, and 5G7 were derived from porcine rotavirus OSU and have been shown to neutralize rotavirus YM but not rotavirus KU (9) . As expected, in the two methods assayed, they recognized only YM VP4 but not KU VP4. When these MAbs were tested for recognition of the chimeric proteins by immunoprecipitation of the vaccinia virus-T7 RNA polymerase-expressed polypeptides, all three MAbs recognized chimera QC, while chimera QKU was recognized only by MAbs 2B6 and 4B2; none of the three MAbs recognized chimera QYM. On the other hand, none of the three chimeric proteins was recognized by these MAbs by immunostaining of Sf9 cells infected with the recombinant baculoviruses. That chimera QYM was not recognized by the VP8 MAbs suggests that it adopts an incorrect conformation and might explain its lack of HA activity despite being the chimeric protein that accumulated to a level equivalent to that of YM VP4. b The proteins were not recognized by the MAbs in the immunocytochemistry assay. The discrepancies observed between the two methods are probably due to a difference in their sensitivities, or in the processing of the samples (lysis under nondenaturing conditions for immunoprecipitation versus formaldehyde fixation of cells for immunostaining), which could differentially influence the structure of the VP4 proteins.
VOL. 69, 1995 69, NOTES 2631 HA domain. The fact that QKU and QC were able to hemagglutinate in a specific fashion indicates that the region between amino acids 93 and 208 of YM VP4 is sufficient to determine the ability of the protein to hemagglutinate. This region could contain the HA domain of the protein, or alternatively it could contain sequences important to maintain the correct structure of the HA domain, which could reside out of this region. Whether the HA domain is included in the region from amino acids 93 to 208 remains to be determined; however, in support of the first alternative is the observation that MAbs directed to VP8 of rotavirus RRV, whose binding sites have been mapped to amino acids 100, 148, and 188, neutralize virus infectivity by preventing the attachment of the virion to a sialic acid-containing structure on the cell surface (19) . In addition, Zhou et al. (24) recently isolated a simian rotavirus SA11 neutralization escape mutant that had lost the ability to hemagglutinate, and the sequence of the VP4 gene of this variant showed the presence of a single amino acid change at position 194 (Tyr to Cys). Also, Fiore et al. (3) , comparing the RRV VP8 region of simian rotavirus RRV with other known viral hemagglutinins, found a distant homology of VP8 with the sigma-1 protein of reovirus type 1. The most similarities between those two proteins were found to occur in VP8 amino acids 1 to 41 (44% identity) and 95 to 126 (45% identity), corresponding to reovirus amino acids 1 to 45 and 91 to 130, respectively. However, the region of VP8 between amino acids 1 and 41 would not seem to be involved in HA, since an Escherichia coli-expressed truncated VP4 polypeptide comprising amino acids 42 to 387 was shown to have HA activity (10) .
A comparison of the amino acid sequences between amino acids 93 and 208 of the VP8 regions of different rotavirus strains (12, 15) showed the presence of two sequence stretches, between amino acids 93 to 112 and 181 to 203, that are well conserved among animal rotavirus strains but are different from the corresponding regions of VP8 of human rotaviruses and the nonhemagglutinating animal rotavirus strain UK, suggesting that they could be involved in determining the HA activity of VP4.
Given the similarities of the interaction of animal rotaviruses with sialic acids on the surface of both erythrocytes and epithelial cells, it is possible that the domain on VP4 responsible for HA could be the same domain that interacts with a sialic acid-containing structure during attachment of the virus to the target cell (5, 16) . This issue should be amenable to study through characterization of the ability of the chimeric proteins reported in this work, and other chimeras, to bind to epithelial cells. This approach should be also helpful in mapping the domain on VP4 for binding to the sialic acid-independent receptor of rotaviruses (16) .
